Biogen Inc. News
Stock Market Today - 5/3: Stocks End Higher Amid Fed Rate Hike Bets; Treasury Yields Ease
Stocks finish higher Tuesday as the Federal Reserve begins its two-day policy meeting amid bets on faster and deeper near-term rate hikes.
Biogen Stock Gains After Q1 Earnings Miss; CEO Michel Vounatsos Exits
"I will be leaving at a time of promise for Biogen, with noteworthy potential for value creation," said departing CEO Michel Vounatsos.
Should Biogen Investors Be Worried About Its Alzheimer's Drug?
A Medicare policy decision might hurt sales of this biotech giant's Alzheimer's drug.
Biogen's ALS Drug Won't Move Forward After Trial Failures
Biogen will stop developing a drug to treat a severe neurodegenerative disease, as it did not show sufficient benefit when tested in trials.
Novartis and Roche Have Expensive Drugs That Scare Away Competitors
A brief snapshot of some medical breakthroughs that are among the costliest in the world.
Morningstar's Five Coping Mechanisms for Bear Market
The S&P 500 is in a bear market, having lost 20% so far this year. So what’s an investor to do?
Economist Roubini: Why Stocks Poised for 50% Wipeout
The stock market is off to its worst start to a year since 1962, with the S&P 500 dropping 21% in the first half of 2022.
Who Is the Mystery Crypto Queen on the Run After an Alleged Scam?
The FBI is offering anyone who helps arrest OneCoin co-founder Dr. Ruja Ignatova $100,000.